Alcohol is responsible for a significant portion of global disease and death, contributing to 2.6 million deaths annually. It plays a role in over 200 medical conditions, including liver disease, cardiovascular disease,

Now, the growing buzz around the use of GLP-1 medications like Ozempic to treat alcohol use disorder finally has new clinical study results that support this theory. (Prior studies have simply found a link between taking a GLP-1 receptor agonist and drinking less—but didn’t go so far as to actually prove that the medications caused people to drink less.

A recent study published in JAMA Psychiatry revealed that Ozempic (semaglutide), a medication commonly used for type 2 diabetes, may reduce alcohol cravings and consumption in adults with alcohol use disorder.